These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37678185)

  • 1. Intestinal proteases.
    Rao S; Grover M
    Curr Opin Gastroenterol; 2023 Nov; 39(6):472-478. PubMed ID: 37678185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging roles of bacterial proteases in intestinal diseases.
    Caminero A; Guzman M; Libertucci J; Lomax AE
    Gut Microbes; 2023; 15(1):2181922. PubMed ID: 36843008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial proteases in IBD and IBS.
    Steck N; Mueller K; Schemann M; Haller D
    Gut; 2012 Nov; 61(11):1610-8. PubMed ID: 21900548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.
    Ceuleers H; Van Spaendonk H; Hanning N; Heirbaut J; Lambeir AM; Joossens J; Augustyns K; De Man JG; De Meester I; De Winter BY
    World J Gastroenterol; 2016 Dec; 22(47):10275-10286. PubMed ID: 28058009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome.
    Hou JJ; Wang X; Li Y; Su S; Wang YM; Wang BM
    Microb Pathog; 2021 Aug; 157():104995. PubMed ID: 34048892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome.
    Edwinson AL; Yang L; Peters S; Hanning N; Jeraldo P; Jagtap P; Simpson JB; Yang TY; Kumar P; Mehta S; Nair A; Breen-Lyles M; Chikkamenahalli L; Graham RP; De Winter B; Patel R; Dasari S; Kashyap P; Griffin T; Chen J; Farrugia G; Redinbo MR; Grover M
    Nat Microbiol; 2022 May; 7(5):680-694. PubMed ID: 35484230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptor signaling in intestinal permeability regulation.
    Pontarollo G; Mann A; Brandão I; Malinarich F; Schöpf M; Reinhardt C
    FEBS J; 2020 Feb; 287(4):645-658. PubMed ID: 31495063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
    Edogawa S; Edwinson AL; Peters SA; Chikkamenahalli LL; Sundt W; Graves S; Gurunathan SV; Breen-Lyles M; Johnson S; Dyer R; Graham R; Chen J; Kashyap P; Farrugia G; Grover M
    Gut; 2020 Jan; 69(1):62-73. PubMed ID: 30923071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease and irritable bowel syndrome: similarities and differences.
    Barbara G; Cremon C; Stanghellini V
    Curr Opin Gastroenterol; 2014 Jul; 30(4):352-8. PubMed ID: 24811054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
    Lee KN; Lee OY
    World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome in quiescent inflammatory bowel disease: a review.
    Burgell RE; Asthana AK; Gibson PR
    Minerva Gastroenterol Dietol; 2015 Dec; 61(4):201-13. PubMed ID: 26426460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucus protectors: Promising therapeutic strategies for inflammatory bowel disease.
    Wu HM; Wei J; Wang K; Qi Y; Wang FY
    Med Hypotheses; 2018 Nov; 120():55-59. PubMed ID: 30220341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of intestinal permeability: The role of proteases.
    Van Spaendonk H; Ceuleers H; Witters L; Patteet E; Joossens J; Augustyns K; Lambeir AM; De Meester I; De Man JG; De Winter BY
    World J Gastroenterol; 2017 Mar; 23(12):2106-2123. PubMed ID: 28405139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction.
    Bonaz B
    Neurogastroenterol Motil; 2022 Oct; 34(10):e14456. PubMed ID: 36097404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host immune interactions in chronic inflammatory gastrointestinal conditions.
    Caminero A; Pinto-Sanchez MI
    Curr Opin Gastroenterol; 2020 Nov; 36(6):479-484. PubMed ID: 32868507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
    Sundin J; Öhman L; Simrén M
    Psychosom Med; 2017 Oct; 79(8):857-867. PubMed ID: 28422780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation.
    Kriaa A; Jablaoui A; Mkaouar H; Akermi N; Maguin E; Rhimi M
    FASEB J; 2020 Jun; 34(6):7270-7282. PubMed ID: 32307770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome.
    Bao CH; Wang CY; Li GN; Yan YL; Wang D; Jin XM; Wu LY; Liu HR; Wang XM; Shi Z; Wu HG
    World J Gastroenterol; 2019 Aug; 25(32):4696-4714. PubMed ID: 31528095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.
    Carroll IM; Maharshak N
    World J Gastroenterol; 2013; 19(43):7531-43. PubMed ID: 24431894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.